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Abstract: In yeast, the main ubiquitin ligase responsible for the sorting of proteins to the
lysosomal vacuole is Rsp5, a member of the Nedd4 family of ligases whose
distinguishing features are a catalytic HECT domain and 3 central WW domains that
bind PY motifs in target proteins. Many substrates do not bind Rsp5 directly, and
instead rely on PY-containing adaptor proteins that interact with Rsp5. Recent studies
indicate that the activities of these adaptors are elevated when they undergo
ubiquitination, yet the mechanism whereby ubiquitination activates the adaptors and
how this process is regulated remain unclear. Here, we report on a mechanism that
explains how ubiquitination stimulates adaptor function, and how this process can be
regulated by the Rsp5-associated deubiquitinase, Ubp2. Our overexpression
experiments revealed that several adaptors compete for Rsp5 in vivo. We found that
the ability of the adaptors to compete effectively was enhanced by their ubiquitination
and diminished by a block of their ubiquitination. Ubiquitination-dependent adaptor
activation required a ubiquitin-binding surface within the Rsp5 catalytic HECT domain.
Finally, like constitutively ubiquitinated adaptors, a Ubp2 deficiency increased both the
adaptor activity and the ability to compete for Rsp5. Our data support a model whereby
ubiquitinated Rsp5 adaptors are more active when “locked” onto Rsp5 via its N-lobe
ubiquitin-binding surface, and are less active when they are “unlocked” by Ubp2-
mediated deubiquitination.
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Deborah Taylor PhD 
Senior Deputy Editor 
Ref.: Ms. No. CURRENT-BIOLOGY-D-16-00701R2 
"A cycle of ubiquitination regulates adaptor function of the Nedd4-family ubiquitin ligase 
Rsp5" 
Dear Dr. Taylor, 
Thank you for your last correspondence that specified editorial points that needed 
addressing as well as a set of final comments from reviewers. The editorial points, which 
mainly focused on re-formatting and updating the key resources table, have been 
addressed, including modification of the abstract to clarify background and new findings. 
Most of the reviewers’ comments originated from confusion that we had caused with the 
order of supplemental figures. That has now been corrected and we have also addressed 





The new aspects of the current revised manuscript are as follows: 
 
The Editorial Points have now been addressed and corrected as suggested. 
 
√ Please finalise the eTOC blurb and Highlights (they still have associated comments 
from one of the authors). 
√  Please reorder the sections of the main paper as follows: title, authors, affiliations, 
author list footnotes, corresponding author(s) e-mail address(es), Summary, 
Introduction, Results, Discussion, Acknowledgments, Author Contributions, Declaration 
of Interests, main figure titles and legends, STAR Methods, and References. 
√  'Fig.' should be changed to 'Figure' throughout, and it should just be 'Figure S1' etc 
not 'Supplemental Figure S1' etc. 
√  The supplemental figure legends should be removed from the main text, as should 
the STAR Methods inventory. 
√ The relationship between main and supplemental data items should be explicitly 
mentioned in the legends of both the main and supplemental data items. 
√ In the Supplemental Information PDF, you should provide each figure followed 
immediately by its legend (and please use uppercase bold panel letter labels in the 
figure itself and in the legend). 
√ Please reconsult the STAR Methods guidelines carefully as you have not provided 
the full details required or used the correct headings. Please also ensure that you 
include the mandatory sections and that all references in the STAR Methods are in 
Cover Letter
numbered format (as in the main text) and included in the References list in the main 
text. 
√ The ‘reagent use table’ in the STAR Methods should be provided as a separate 
Excel table named Table S1. 
√  The Key Resources Table should be provided as a separate Word document. 
Please also reconsult the guidelines for this table as there is a lot of missing 
information: you need to include all reagents mentioned in the STAR Methods, i.e. all 
chemicals, devices etc, and you also must include identifier information. Please include 
the URLs for the software used in the study. All references in the Key Resources Table 
need to be in numbered format (as in the main text) and included in the References list 
in the main text. 
√ The abstract should be reworked a little to clarify the background to the study and the 





REVIEWER COMMENTS:  
We are happy the reviewers appreciated out work and find the remaining comments helpful.  
These last concerns have now been addressed by including an up-to-date figure set of the 
supplemental figures. These include the following: 
Rev2, point 3. The authors refer to new and important IP data (Fig S3c,d), but I can't 
find it. There is a mix up in the labelling of the supplemental figures. There are 2 
FigS2s (presumably the second is S3). S3e is incorrectly labelled as c, the is a 
structure panel referred to as d, which has no legend. The IP panels referred to in the 
text are missing from my version of the manuscript. 
Rev3 Supplemental Fig. S3: 
-This figure is labeled as Fig. S2 
-The legend describes IP experiments for panel C, but the figure shows a cartoon of 
the mating response experiment, with accompanying quantification. No IP is shown. 
-The legend describes IP experiments for panel D, but the figure shows a structural 
rendering of Rsp5 
-The legend describes panel E as the mating experiment actually shown in panel C. 
There is no panel E in the figure. 
-The figure shows a graph underneath panel D that has no callout and no appropriate 
description in the legend. The x-axis labels are missing a description of what the 
middle "+" signs represent (upper = vector, lower = RSP5, middle = ???) 
-In the middle of the legend for Fig. S3e is the following sentence: "Cells were 
transformed with vector control, myc-Hua1, Ub-myc-Hua1 and myc-Hua1∆N before the 
assay was repeated in cells grown in YPD followed by a 20-minute period of growth in 
YPG to inhibit production of new Ste3." Presumably this should be growth in YPG, 
followed by a switch to YPD to inhibit production of Ste3? 
Rev3  Supplemental Fig. S1: 
-The legend has two separate callouts for panel E. The first of these matches the panel 
shown in Fig. S1e, while the second references data that is not included anywhere in 
the figure. 
All other concerns were also addressed as follows. 
Rev3 General 
Based on the revisions provided, this manuscript should in principle be appropriate for 
publication in Current Biology. Before final acceptance of the manuscript, the authors 
should very carefully go through all figures, legends, and in-text callouts, as there are 
still issues in agreement between these. Some examples of discrepancies and/or 
legends that would benefit from clarification are listed below. 
> Helpful. We have gone through and made sure legends match figure subpanels. We 
have also gone through systematically and found quite a few panels that were not 
called out and corrected this. 
Rev3,  Fig. 5: 
-The legend for panel D is somewhat unclear. Cells are reported to be constitutively 
expressing Ub-Hua1, although it is under a regulated (CUP1) promoter. Presumably 
this means that cells were grown in the constant presence of Cu2+; this should be 
stated more explicitly. The legend references galactose (GAL) and dextrose (DEX) 
media, but these are listed in the figure as (YPG) and (YPD), respectively 
> Thank you. Great catch, this was not a constitutive promoter. Text is now changed to 
CUP1 + copper. Also changed YPD – DEX / YPG - GAL 
Rev3,  Fig. 5: Fig. 7B: 
-The second sentence of the legend could be clarified by stating, "Cells were imaged 
prior to (- Met) or following (+ Met) 1 h treatment with methionine." 
> Thank you. We incorporated this change. 
Rev2 point 1. My point is that almost any over-expressed protein would likely have high 
MW polyubiquitinated forms (or at least the authors could have shown this is not the 
case by actually expressing a control protein!). Their model predicts that these 
adaptors should be mono-ubiquitinated (i.e. regulatory), but there is no evidence 
provided for Rim8 and Art1 that this is the case. Perhaps there is some reason why 
these adaptors are regulated by polyubiquitination? The authors could at least allude to 
the fact that in some respects these data are unexpected. 
> Previous publications indicate that different lysines on Rsp5 adaptors can undergo 
different types of ubiquitination (mono vs poly) that in turn could be regulatory vs 
degradative. We have referred to those papers to highlight the reviewer’s point.  
Importantly, previous studies have demonstrated a sizable pool of mono-ubiqutinated 
Art1 and Rim8. Our own studies (Figure S2D) confirm a stable pool of mono-
ubiquitinated Art1.   
 
Rev2 point 2. Figure 2B. I still dislike the crop, and almost certainly the box would 
exclude any 8kDa increase in Hua1deltaN (the alteration in MW caused by addition of 
the 8kDa ubiquitin moiety between Hua1 and Hua1-Ub provides an excellent 
calibration). Why not simply show the increased exposure blot in FigS2d? The 
outcome is clear here. 
> We have left the cropped version as it is the only way to show the bands without 
excessive contaminating signal from the unmodified species, which could equally 
confuse the figure panel. This was sufficient for another reviewer and with the inclusion 
of the full panel in supplemental data, we feel that this satisfies the curiosity of Rev2 on 
this point. The supplemental figure – now called out in the legend - clearly shows there 
is no ubiquitinated band in the ∆N version. 
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In yeast, the main ubiquitin ligase responsible for the sorting of proteins to the lysosomal vacuole 
is Rsp5, a member of the Nedd4 family of ligases whose distinguishing features are a catalytic 
HECT domain and 3 central WW domains that bind PY motifs in target proteins. Many substrates 
do not bind Rsp5 directly, and instead rely on PY-containing adaptor proteins that interact with 
Rsp5. Recent studies indicate that the activities of these adaptors are elevated when they undergo 
ubiquitination, yet the mechanism whereby ubiquitination activates the adaptors and how this 
process is regulated remain unclear. Here, we report on a mechanism that explains how 
ubiquitination stimulates adaptor function, and how this process can be regulated by the Rsp5-
associated deubiquitinase, Ubp2. Our overexpression experiments revealed that several adaptors 
compete for Rsp5 in vivo. We found that the ability of the adaptors to compete effectively was 
enhanced by their ubiquitination and diminished by a block of their ubiquitination. Ubiquitination-
dependent adaptor activation required a ubiquitin-binding surface within the Rsp5 catalytic HECT 
domain. Finally, like constitutively ubiquitinated adaptors, a Ubp2 deficiency increased both the 
adaptor activity and the ability to compete for Rsp5. Our data support a model whereby 
ubiquitinated Rsp5 adaptors are more active when “locked” onto Rsp5 via its N-lobe ubiquitin-





Members of the Nedd4-related (neural precursor cell expressed, developmentally downregulated 
4) ubiquitin (Ub) ligase family regulate a broad array of biological processes including the 
degradation of cell surface proteins by initiating their Ub-dependent sorting to the lumen of the 
endosome as well as trafficking to endosomes from the Golgi and plasma membrane [1, 2]. These 
ligases are characterized by an N-terminal lipid interacting C2 domain, between one and four 
protein-protein interaction WW domains, and a homologous to E6AP carboxyl terminus (HECT) 
catalytic domain, responsible for carrying a thiol-ester-linked Ub at its active site cysteine residue, 
which is ultimately transferred to substrates [3]. Whereas humans have nine Nedd4-family ligases, 
the yeast Saccharomyces cerevisiae has only one, Rsp5, which ubiquitinates a wide range of 
substrates [4, 5]. Although a variety of substrates can directly engage Nedd4-ligases by binding 
their WW domains using PY peptide (sequence [L/P]PxY) motifs, other substrates engage 
indirectly by binding adaptor proteins, which use their own PY motifs to bridge association with the 
ligase [5, 6]. Adaptor proteins for Rsp5 include a diverse group of cytosolic proteins, many that 
share an arrestin-related motif, and also various membrane proteins such as Sna3 and Bsd2 that 
recruit Rsp5 to membrane proteins with which they associate [7-12].  
How this complex system is regulated is not yet fully clear. First, many of the Rsp5-adaptor 
proteins become ubiquitinated themselves, as would be expected for proteins that directly 
associate with an active ligase [8, 13-15]. Yet, through an unknown mechanism, at least some of 
these adaptors require specific ubiquitination by Rsp5 to achieve their full activity [9, 16, 17]. Rsp5 
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also associates with the deubiquitinating enzyme Ubp2 using the bridging protein Rup1 [13, 18]. 
Whereas Rsp5 catalyzes formation of K63-linked polyubiquitin chains, Ubp2 dismantles K63-linked 
Ub-chains leading to the initial suggestion that Ubp2 simply antagonizes Rsp5 function. This is 
demonstrated in part by the hyperaccumulation of K63-polyubiquitin chains in ubp2∆ null mutants 
[18] and the ability of Ubp2 to diminish ubiquitination of Rsp5 substrates in vitro [13, 19]. However, 
loss of Ubp2 causes lysosomal trafficking defects for a wide range of membrane protein cargoes 
suggesting that Ubp2 somehow stimulates Rsp5 function [13, 20-22]. Finally, the HECT domain of 
Rsp5, as well as other Nedd4-family members, contains a site that mediates a non-covalent 
interactions with Ub and is required for full-activity of Rsp5 in vivo [23-26]. Here we propose a 
model that explains how these molecular features are coordinated to regulate Rsp5 activity, 
thereby distributing that activity appropriately to its many substrates and adaptors. Our data 
support a model whereby adaptors become ubiquitinated and bind tighter to Rsp5 via its WW 
motifs and Ub-binding surface. Tighter association with Rsp5 allows the adaptor to direct Rsp5 
activity to only a subset of cognate targets, effectively depleting ubiquitination of non-cognate 
substrates. Ubp2 plays a contravening role to deubiquitinate adaptors, allowing them to disengage 





Hua1 is an Rsp5 adaptor that requires ubiquitination for full activity 
 Hua1 recruits Rsp5 to the ESCRT-0 complex (Vps27 and Hse1), which is part of the overall 
ESCRT apparatus required for sorting of ubiquitinated membrane proteins into the MVB pathway 
[21]. Association of Rsp5 with ESCRT-0 is required for the efficient MVB sorting of ubiquitinated 
cargo proteins such as Cps1. Hua1 helps recruit Rsp5 to ESCRT-0, by binding both Rsp5 and the 
SH3 domain Hse1. Rsp5 can also be recruited to ESCRT-0 via a direct interaction with the C-
terminal PY motif of Hse1 (Figure 1A, S1A). Although loss of Hua1 alone has no discernable 
cargo sorting phenotype, loss of Hua1 does cause defects in MVB sorting in cells that express a 
mutant version of Hse1 that cannot directly bind Rsp5 [21]. Cps1 also relies on other mechanisms 
to engage Rsp5 for its efficient trafficking to the vacuole [27], consistent with the idea that Hua1 
function is restricted to only a subset of cargoes engaging ESCRT-0 [21]. Thus, Hua1 serves as an 
adaptor for Rsp5, allowing Rsp5 activity to be localized near cargo undergoing MVB sorting. Mass 
spectrometry has previously shown Hua1 is ubiquitinated on the N-terminal residues K3 and K18 
[28, 29]. We confirmed that Hua1 was ubiquitinated, predominantly found as a monoubiquitinated 
species (Figure S1B, S1C). When expressed as an HA-epitope tagged protein (Figure 1B) or a 
myc-epitope tagged protein (Figure 1C), a higher molecular weight species of Hua1 was readily 
isolated under denaturing conditions on Ni-NTA-linked sepharose using lysates from cells 
expressing 6xHis-tagged Ub. Similarly, the Rsp5 adaptors Rim8 and Ldb19 /Art1 could be 
observed in their ubiquitinated forms by this method, confirming previous studies showing these 
adaptors are ubiquitinated by Rsp5 to both regulate and in some cases, to induce degradation [9, 
16, 30]. Previous experiments on other Rsp5 adaptors showed substitution of their ubiquitinated 
lysine with arginine diminished function [9, 16, 31]. This was also true for Hua1, which was 
revealed by comparing the function of wild-type Hua1 to a K3R, K18R mutant lacking ubiquitinatable 
lysines (Hua1K>R). Both versions of Hua1 were expressed under the native HUA1 promoter, and 
both contained a modified myc epitope (myc*: EQRLISEEDL; which substituted the lysine in the 
original tag for arginine). The expression levels of both wild-type (WT) myc*-Hua1 and the myc*-
Hua1K>R mutant were comparable by immunoblotting (Figure 1D, S1C), and overexposure of the 
blot allowed detection of a slower migrating band corresponding to the ubiquitinated form for WT 
myc*-Hua1, which was not observed for myc*-Hua1K>R. In cells lacking Hua1 and also carrying an 
Hse1 mutant lacking is PY Rsp5-binding motif (hse1∆rsp5), expression of myc*-Hua1 restored MVB 
sorting of GFP-Cps1 but expressing the myc*-Hua1K>R mutant did not (Figure 1E). Together, these 
results suggest that like other Rsp5 adaptors [9, 16, 17], Hua1 requires ubiquitination to become 
fully active.  
 
Adaptor protein over-expression interferes with non-cognate Rsp5-dependent processes 
Preliminary experiments indicated that overexpression of Hua1 caused dominant negative 
effects on other Rsp5-dependent processes. These data implied that overexpression of Hua1 
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competes and displaces other adaptors from Rsp5, with a concomitant decrease in ubiquitination 
of their respective substrates. Such observations are consistent with the previous observations 
showing overexpression of Rsp5 adaptors inhibits MVB sorting of their non-cognate cargoes [8, 
32-34]. We exploited this observation to further investigate the effect of ubiquitination of Hua1. We 
compared the effects of overexpressing Hua1 with a Ub-Hua1 fusion, in which Ub (aa 1-75) was 
fused to the N-terminus of Hua1 to mimic a constitutively ubiquitinated form of Hua1 (Figure 2A). 
As a control, we included a truncation mutant of Hua1 (Hua1∆N) in which the N-terminal region 
containing the K3 and K18 ubiquitination sites, as well as an Rsp5-binding PY motif were removed. 
The levels of each of these constructs from a low copy plasmid were assessed following induced 
expression from the CUP1 promoter (Figure 2B, S2D). The level of WT myc-Hua1 was 
comparable to that of the myc-tagged Hua1∆N, whereas the levels of the myc-tagged Ub-Hua1 
fusion were distinctly lower. Increased exposure showed that myc-Hua1 had additional 
ubiquitinated species, including a band that co-migrated with Ub-Hua1 and a higher band 
consistent with di-ubiquitinated Hua1 in each lane, indicating that a portion of myc-Hua1 was 
ubiquitinated. Hua1∆N showed no evidence of ubiquitination (Figure 2B). Overexpressing Hua1 
inhibited growth at 37°C and growth inhibition was even more profound upon overexpressing Ub-
Hua1 (Figure 2C). Although this difference was observed at different levels of copper induction, 
we presume inhibition of Ub-Hua1 is near maximal, because very high copper levels copper levels 
were required for Hua1 to cause defects as severe as Ub-Hua1 (Figure S1E). In contrast, 
overexpressing Hua1∆N or Hua1K>R mutants that do not get ubiquitinated had no effect (Figure 2D). 
Hua1 overexpression caused defects in the Rsp5-dependent sorting of GFP-tagged membrane 
proteins along the MVB pathway into the vacuolar lumen. In general, these defects were more 
pronounced upon expression of the ‘constitutively ubiquitinated’ Ub-Hua1 fusion protein and were 
absent upon expression of the Hua1∆N mutant. We found that overexpressing Hua1 and Ub-Hua1 
had profound defects in sorting Sna3-GFP to the vacuole (Figure 2E). We and others have 
previously shown that Rsp5-dependent mono-and di-ubiquitinated species of Sna3 are detectable 
by immunoblot [35, 36].  We took advantage of this to show that the levels of Sna3-HA are 
stabilized in Hua1-overexpressing cells, whilst the relative proportion of ubiquitinated Sna3-HA was 
reduced (Figure 2F, S2A-C). Overexpressing Ub-Hua1 diminished the proportion of ubiquitinated 
Sna3 to the same extent as Hua1 overexpression despite its dramatically reduced levels, 
suggesting the inhibitory effects of Ub-Hua1 were more potent. Similarly, overexpressing Hua1 
caused mis-sorting of GFP-Cps1 and Gap1-GFP, yet had little effect on Ste3-GFP or Mup1-GFP in 
the presence of methionine. In contrast, expressing Ub-Hua1 caused mis-sorting of all of these 
cargoes and caused a more severe phenotype for Gap1-GFP (Figure 2G). We further note that 
expression of Ub-Hua1 appears to elevate levels of surface cargoes (Ste3, Gap1, Mup1) at the 
plasma membrane when compared with Hua1 overexpression, suggesting the more efficient 
ubiquitinated competitor interfere with Ub-dependent membrane trafficking steps that ultimately 
lead proteins into the vacuole [2]. These effects can collectively be explained by Hua1 titrating 
available Rsp5, competing away adaptors, such as Bul1/2 or Art1 that mediate Rsp5-dependent 
ubiquitination of Gap1 and Mup1, respectively, or the ability of Rsp5 to engage Sna3 and Cps1 
directly through their Rsp5 binding motifs [27, 35]. Moreover, Ub-Hua1 was more potent in causing 
these effects, highlighting the importance of ubiquitination in the ability of Hua1 to affect Rsp5 
function. We also examined the effects of Hua1 overexpression on another Rsp5-dependent 
process, the proteolytic processing of Rim101 into an active transcription factor in response to 
alkaline stress, which requires the arrestin-related Rsp5 adaptor Rim8 [17, 32]. In cells shifted from 
pH 3.5 to pH 8.0 for 25 minutes, Rim101-HA was processed to a lower molecular weight form as 
predicted. Yet, overexpression of Hua1 and Ub-Hua1 blocked alkaline-induced processing of 
Rim101-HA (Figure 2H). We note that the extent of Rim101 processing varies among different 
parental strains (Figure S3A), yet the ability of Hua1 overexpression to inhibit Rim101 processing 
was observed for both strains tested. 
 
Cognate activities of adaptors proteins are stimulated by ubiquitination 
We next determined how these observations could be extended to explain the function of 
other Rsp5 adaptors. Art1 is an Rsp5 adaptor that promotes ubiquitination and sorting of Mup1 
and Can1 into the vacuole lumen, a process that is induced by their respective substrates 
methionine and arginine (Figure 3A). Art1 undergoes ubiquitination on K486 and a K486R mutant 
has a diminished ability to mediate Rsp5-dependent sorting of Can1 to the vacuole [9]. Consistent 
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with these studies, we found that a portion of overexpressed HA-epitope-tagged Art1 was 
ubiquitinated, whereas no ubiquitinated species was observed for the overexpressed K486R mutant 
(Art1-HAK>R) construct (Figure 3C). Overexpression of Art1-HA caused Mup1 to traffic to 
endosomes in media lacking exogenous methionine, showing that Art1 overexpression partially 
bypassed the requirement of substrate induced Mup1 downregulation (Figure 3B). This effect was 
far more dramatic upon overexpression of Art1-HA-Ub fusion protein, where Ub (G76S) was fused 
onto the C-terminus. Here, Mup1-GFP sorted more efficiently through the MVB pathway to 
accumulate within the vacuole. This enhanced activity of Art1-Ub towards its cognate cargo Mup1 
was not due to a level of expression that was higher than Art1-HA alone (Figure S2D). In contrast, 
overexpressing Art1-HAK486R to levels comparable to WT Art1-HA had no effect on Mup1-GFP 
sorting (Figure 3B, 3C). To verify the role of Rsp5 in vacuolar sorting of Mup1-GFP, we found 
antagonizing Rsp5 activity with fusion of a deubiquitinating enzyme [35], even in the presence of 
methionine, completely blocked Mup1-GFP sorting. A similar pattern was found in the ability of 
Art1 to inhibit non-cognate processes when overexpressed (Figure 3D). Expressing myc-Art1 from 
the copper inducible CUP1 promoter inhibited growth at 37°C mirroring the inhibitory effects on 
growth resulting from overexpressing Hua1. Although expressed to similar levels, the myc-epitope-
tagged Art1K486R did not cause a growth defect at elevated temperature. Similarly, overexpressing 
Art1-HA had a slight yet discernable defect in MVB sorting of GFP-Cps1, which uses an Art1-
independent means of recruitment to Rsp5 [21, 27]. This dominant-negative sorting defect was 
very dramatic upon expressing an Art1-HA-Ub fusion protein, whereas no defect was observed 
upon overexpressing Art1-HAK486R, again underscoring the role ubiquitination plays on the ability of 
Art1 to co-opt Rsp5 (Figure 3G). We also examined Rim8, an Rsp5 adaptor that conveys signals 
from a plasma membrane protein complex containing Rim21 to the proteolytic processing of the 
Rim101 transcription factor [37], a pathway that is normally triggered when cells are shifted from 
acidic to alkaline growth conditions (Figure 3E). We found that overexpressing V5-epitope-tagged 
Rim8 was sufficient to cause Rim101 processing in cells maintained in acidic growth conditions, 
showing that an excess of Rim8 allowed it to bypass the normal trigger of alkaline shift (Figure 3F, 
S3B). Rim8 is known to be ubiquitinated at K521, and overexpressing a Rim8 K521R mutant 
(Rim8K>R) had no effect on promoting promiscuous Rim101 processing in acidic conditions. The 
effect of overexpressing Rim8 on its non-cognate substrate GFP-Cps1 mirrored the effects 
observed for Art1. Rim8-V5 expression caused minor defects in sorting of GFP-Cps1, yet 
overexpression of Rim8-V5-Ub, a ‘constitutively ubiquitinated’ version of Rim8 in which Ub(G76S) 
was fused to the C-terminus, caused a profound defect in GFP-Cps1 sorting (Figure 3G) despite 
the fact that the overall levels of Rim8-V5-Ub were demonstrably lower that the WT Rim8-V5 
protein (Figure 3F). 
 
Ubiquitinated adaptors regulate Rsp5 activity via direct binding  
Consistent with previous observations [10, 11, 33, 38, 39], the above data indicate that 
Rsp5 is limiting and that adaptors compete for occupancy on Rsp5 to effectively direct activity to 
their substrates. Consequently, this would diminish the ability of Rsp5 to work with other adaptors 
that target non-cognate substrates and processes. To explain these effects we considered a model 
in which ubiquitination of Rsp5 adaptors allows them to lock onto Rsp5, with enhanced 
engagement through the WW domains of Rsp5 in combination with the non-covalent Ub-binding 
surface (UBS) within the N-lobe of the HECT catalytic domain, which has been described for a 
number of HECT domains including that of Rsp5 [24-26, 40]. This can explain how Rsp5 adaptors 
appear more functionally active towards their cognate substrates and how they can better compete 
against other Rsp5 adaptors when they are ubiquitinated (Figure 4). As confirmation that the 
dominant-negative effects of Hua1 overexpression are mediated through its ability to work as a 
competitive Rsp5 inhibitor, we found that the inhibitory effects of myc-Hua1 overexpression on 
growth at 37°C were suppressed by overexpression of Rsp5 (Figure 5A). In addition, 
overexpressing Rsp5 suppressed the defect in downregulation of Ste3-GFP caused by 
overexpressing myc-Ub-Hua1, diminishing the plasma membrane localization of Ste3 (Figure 5B). 
This was also observed using an assay that couples mating efficiency to the turnover of cell 
surface Ste3 (Figure 5C, 5D, S3E). Here, production of Ste3 is under control of the GAL1 
promoter, which allows the synthesis of new Ste3 to be blocked when cells are shifted from 
galactose to dextrose, and the ability to mate at increasing times after the shift is proportional to 
the level of pre-existing Ste3 that resists downregulation and remains at the cell surface [41]. In 
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cells carrying vector or Hua1∆N, mating was virtually abolished after 20 min of growth in dextrose. 
However, cells overexpressing myc-Ub-Hua1 or myc-Hua1 retained the ability to mate, albeit at a 
slightly lower frequency (Figure S3E). Importantly, overexpressing Rsp5 suppressed the effect Ub-
Hua1 overexpression, greatly diminishing the residual rate of mating following a shift into dextrose 
(Figure 5D). To determine if the potency of Ub-Hua1 as an Rsp5 competitor was mediated through 
the N-lobe UBS of the Rsp5-HECT domain, we compared the effects of Hua1 and Ub-Hua1 
overexpression in wild-type cells and cells carrying the Rsp5 F618A mutation (rsp5
∆Ub , Figure 4) 
that neutralizes the N-lobe UBS [23]. As reported earlier, the rsp5∆Ub mutant is less active overall 
[23], therefore myc-Hua1 overexpression is sufficient to compromise growth at 37°C whereas 
Hua1∆N had no effect (Figure 5E). Importantly, unlike wild-type cells, the rsp5∆Ub mutant showed 
no difference in the level of growth inhibition by myc-Hua1 vs myc-Ub-Hua1, supporting the model 
that the effect of ubiquitinated-adaptors is mediated through the N-lobe UBS (Figure 4). The 
model further predicts that ubiquitinated adaptors associate better with Rsp5. Co-
immunoprecipitation experiments using lysates from yeast expressing the myc-Hua1 variants 
showed that Rsp5 associated with both Hua1 and Ub-Hua1, yet that association was greatly 
diminished for Hua1∆N, lacking its canonical PY motif and N-terminal ubiquitination sites (Figure 
5F, S3C). Importantly, the proportion of Rsp5 co-immunoprecipitated with myc-Ub-Hua1 was far 
higher than for myc-Hua1, indicating that Ub-Hua1 binds Rsp5 better than Hua1 alone. This was 
confirmed through in vitro binding studies wherein Hua1 and Ub-Hua1 were fused to the 
streptococcal protein G as a solubility tag and the HA epitope for immuno-detection and produced 
in bacteria. Lysates were mixed and allowed to bind beads coated with maltose-binding protein 
(MBP) or MBP fused to full-length Rsp5. Immunoblotting fractions revealed that Ub-Hua1 bound 
with much higher efficiency to MBP-Rsp5 than Hua1 (Figure 5G). Finally, immunoprecipitation 
experiments using cells carrying WT RSP5 or mutant rsp5∆Ub allele as their sole copy showed that 
the binding of Ub-Hua1 to Rsp5 relies on an intact UBS, as significantly less Ub-Hua1 was 
recovered from cells expressing the rsp5∆Ub (F618A) allele (Figure S3D).  
 
The deubiquitinating enzyme Ubp2 regulates adaptor protein activity  
Rsp5 forms a complex with the deubiquitinating enzyme Ubp2 via Rup1, and loss of Ubp2 
compromises many Rsp5-dependent functions [13, 18, 20, 21]. Under the proposed model, one 
function of Ubp2 could be to deubiquitinate Rsp5 adaptors, facilitating their ability to disengage 
Rsp5 and allow for exchange of new adaptors. This model would predict loss of Ubp2 inhibits 
adaptor exchange and diminishes the pool of ‘free’ Rsp5 available for adaptor engagement, 
resulting in failure to ubiquitinate the full repertoire of substrates (Figure 4). Ubp2 associates with 
Rsp5 via the linker protein Rup1 (Figure 6A), this association is not stoichiometric in vivo, 
however, since only a portion of these components are recovered by immunoprecipitation [20]. 
According to the model, ubp2∆ mutants would have no way of efficiently ‘unlocking’ ubiquitinated 
adaptors from Rsp5. More abundant adaptors would be converted to longer-lived stronger 
competitors that would compromise myriad Rsp5 functions and result in the plethora of defective 
Rsp5-dependent cargo sorting events previously observed [13, 20-22]. In this scenario, Hua1 
would become a much more effective inhibitor, on par with the ‘constitutively ubiquitinated’ Ub-
Hua1 fusion protein, since it would remain ubiquitinated once bound to Rsp5. Indeed, we found 
that the inhibitory effect of Hua1 and Ub-Hua1 were very similar in ubp2∆ and ubp2∆ rup1∆ 
mutants as measured in growth assays at 37°C (Figure 6B), in contrast to the differential effects of 
Hua1 compared with Ub-Hua1 overexpression observed in WT cells. In addition, Hua1 and Ub-
Hua1 were equally potent at inhibiting MVB sorting of Mup1-GFP into the vacuole of ubp2∆ cells, 
whereas in WT cells, only Ub-Hua1 could inhibit sorting of Mup1-GFP (Figure 6C, S4A). The idea 
that Rsp5 is ineffective in ubp2∆ mutants because it is locked into ubiquitinated complexes that 
sequester its ability cycle amongst a variety of adaptors was supported by Rsp5 overexpression 
experiments. Here, we found that overexpressing Rsp5 corrected the sorting defects of GFP-Cps1 
in ubp2∆ mutants (Figure 6D). We also found that WT and ubp2∆ cells had similar levels of myc*-
Hua1 and myc*-Hua1K>R (Figure 6E, S4B), supporting the hypothesis that Ubp2 does not promote 
Rsp5 processes in the cell solely by elevating levels of Rsp5 adaptor proteins.  
To fully test the model, we assessed whether Rsp5-dependent endocytosis of Mup1 was 
promoted or inhibited by cognate and non-cognate Rsp5 adaptor proteins in WT and ubp2∆ cells 
(Figure 7A). In WT cells, as described above, overexpressing Art1 was sufficient to drive Mup1-
GFP into endosomes in the absence of methionine. Downregulation was more profound in WT 
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cells expressing Art1-Ub, where the majority Mup1-GFP was found within the vacuole lumen. In 
ubp2∆ cells, the degree of Mup1 downregulation was extensive for both Art1 and Art1-Ub 
overexpression, suggesting that in the absence of Ubp2, Art1 functions as strongly as a 
‘constitutively ubiquitinated’ version (Figure 7B, 7C, S4C). Other Rsp5 adaptors, for which Mup1 is 
a non-cognate substrate and would therefore compete with Art1 for Rsp5-dependent 
downregulation of Mup1, behaved with the same profile. In WT cells, addition of methionine 
caused efficient sorting of Mup1 from the cell surface to the vacuolar lumen. However, 
overexpressing myc-Ub-Hua1 or Rim8-V5-Ub antagonized Mup1 sorting to the vacuole, causing a 
portion Mup1-GFP to persist at the cell surface (Figure 7C, 7D). Inhibition of methionine-
stimulated downregulation of Mup1-GFP was not observed by overexpressing myc-Hua1 or Rim8-
V5 that were not fused to Ub, consistent with the preceding experiments showing that 
‘constitutively ubiquitinated’ forms of Rsp5 adaptors are stronger competitive inhibitors than their 
natural counterparts. Importantly, in ubp2∆ cells, the wild-type forms of Hua1 and Rim8 were just 
as inhibitory as their Ub-fused counterparts. Inhibition of Mup1-GFP downregulation was not 
observed when overexpressing either Hua1∆N nor Rim8K>R, suggesting that Hua1 and Rim8 






Rsp5 can either directly bind substrates or use a variety of adaptor proteins to facilitate 
substrate ubiquitination [5, 7, 9-11]. Rsp5 adaptors also undergo ubiquitination, and for some such 
as Art1, Rod1, Csr2, and as shown here for Hua1, ubiquitination is required for them to achieve 
their full function [9, 16, 31]. We find that adaptor ubiquitination enhances activity towards cognate 
substrates whilst also inhibiting ubiquitination of non-cognate substrates, supporting a model in 
which ubiquitinated adaptors better compete for occupancy on Rsp5. In some cases, such as Art1, 
translational fusion of Ub greatly potentiates activity towards its cognate substrates such as Mup1, 
which is downregulated even in the absence of its substrate methionine. In all cases examined 
here, attachment of Ub onto adaptors potentiated their ability to disrupt Rsp5-dependent regulation 
of non-cognate substrates, likely reflecting their enhanced ability to co-opt a limited pool of Rsp5. 
Previous studies have also provided evidence for competition amongst Rsp5 adaptors. For 
instance, overexpressing Sna3, Ssh4, or Ear1 inhibits Rsp5-dependent downregulation of Tat2 for 
which Art1 and Art2 serve as cognate adaptors [10, 11, 33, 38, 39]. Additionally, overexpressing 
the Aly1, Aly2, or Ssh4 adaptor proteins blocks Rsp5-dependent endocytosis of Gap1, for which 
Bul1 and Bul2 serve as cognate adaptors [34, 38, 42]. Moreover, deletion of Bul2 potentiates the 
ability of Bsd2 to downregulate Smf1 and deletion of Bul1 allows for better downregulation of Can1 
[43]. Our studies indicate that ubiquitinated versions of adaptors compete better, providing an 
explanation for how ubiquitination appears to ‘activate’ adaptors and potentiate their activity.  
This model is further supported by our observations that artificially ubiquitinated Hua1 binds Rsp5 
better in vitro and in vivo, providing a biochemical correlate for how ubiquitinated adaptors might 
better direct Rsp5 to their cognate substrates while also depriving other adaptors from occupancy 
on Rsp5 (Figure 5).  
Translational fusion of ubiquitin converted adaptors into potent competitors, but there may 
be additional conformational criteria to convert an adaptor into a form that can work more potently 
on its cognate substrates.   Art1, Rim8, and Hua1 undergo site-specific ubiquitination, and these 
particular sites may be required in some contexts to form a specific quaternary structure with Rsp5 
and their substrate. This may explain why activity of the Rim8K>R mutant towards its cognate 
substrate within the Rim101 pathway was not restored upon Ub-fusion (Figure 3). Overall, our 
data for Rim8 are largely consistent with previous studies that demonstrate a role for ubiquitination 
of Rim8, which have yielded seemingly disparate results. In Aspergillus, the PalF/Rim8 Rsp5 
adaptor is required for processing of PacC/Rim101 in response to a shift to alkaline pH. 
Overexpressing a translational PalF-Ub fusion protein causes promiscuous pH-independent 
activation of the PacC/Rim101 whereas PalF expression alone does not [30]. In Saccharomyces 
cerevisiae, however, a Rim8K521R mutant still supports pH-dependent activation of the Rim101 
pathway [17]. We found that overexpressing Rim8, whether it was fused to Ub or not, caused the 
promiscuous pH-independent activation of the Rim101 pathway, suggesting that the threshold for 
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activating the RIM101 pathway may be low in the strains we tested (Figure 3F). This effect was 
dependent on Rim8 ubiquitination since overexpressing the Rim8K521R mutant had no effect. These 
data combined with the observation that fusion of Ub onto Rim8 elicited a stronger inhibitory effect 
on non-cognate substrates such as Mup1-GFP aligns again with the idea that ubiquitination of 
Rim8 potentiates its ability to direct Rsp5 towards activating the Rim101 pathway but that these 
enhancing effects are not strictly required in S. cerevisiae laboratory strains, possibly due to a 
sensitized system. 
 We propose that the sensor that responds to adaptor ubiquitination is Rsp5 itself, via the 
Ub-binding surface (UBS) within the N-lobe of the HECT catalytic domain [23-25]. Inactivating this 
surface abolished the advantage that Ub-Hua1 had over Hua1 in causing dominant-negative 
effects on Rsp5 function and decreased association with Rsp5 in immunoprecipitation experiments 
(Figure 5, S3C). These data suggest a mechanism whereby the Rsp5 UBS provides an additional 
interface to help ‘lock on’ adaptors that also connect with Rsp5 WW domains via their PY motifs. 
An analogous dual-site binding effect has also been observed between Smurf2 and its substrate 
RhoA, which binds better to the Smurf2 HECT domain when presented as a Ub-fusion protein [26]. 
The Rsp5 Ub-binding surface may also play additional stimulatory roles in vivo. Analysis of Rsp5 
and other Nedd4-family members in vitro shows that the UBS is important for polyubiquitin chain 
elongation, with a minor role in the initial mono-ubiquitination of substrate [24-26]. Although mono-
ubiquitination of plasma membrane cargoes is sufficient for their MVB sorting and downregulation 
[44], any loss of the ability to elaborate a longer K63 chain, that would have more avid binding to 
Ub-sorting receptors, would likely compromise the ability of Rsp5 to downregulate membrane 
protein cargoes. One speculation is that the occupancy of the Ub-binding surface by a 
ubiquitinated adaptor protein may constrain the activity of the Rsp5-UBS resulting in the addition of 
mono-Ub and short K63-linked chains on membrane protein substrates. Whereas in other 
contexts, such as ubiquitination of heat damaged cytosolic proteins, the Rsp5-UBS might be 
unfettered and potentiate formation of longer chains that include K48 linkages [28, 40]. Aside from 
these two potential stimulatory activities for the UBS, an inhibitory role has also been proposed 
[45]. In this instance, the UBS binds to autoubiquitinated Rsp5, creating an oligomer that is less 
active in vitro. Since eliminating the Rsp5 UBS itself clearly inhibits Rsp5 activity in vivo rather than 
stimulate it by eliminating a sole inhibitory function, it will be interesting to determine how these 
potential stimulatory and inhibitory mechanisms coordinate with one another physiologically.  
Overall, this model specifies a process whereby adaptors constantly compete with each 
other for occupancy with Rsp5. Upon binding, they can undergo ubiquitination and occupy Rsp5 
more efficiently. The model also explains how Rsp5 association with the deubiquitinating enzyme 
Ubp2 can promote Rsp5 activity in general. Ubp2 clearly antagonizes Rsp5 activity in vitro and can 
also oppose Rsp5 activity on some substrates in vivo [13, 18, 19]. Yet how Ubp2 plays a 
stimulatory role in promoting the downregulation and MVB sorting of numerous membrane proteins 
as well as degradation of cytosolic proteins is difficult to reconcile with a simple view of this 
relationship [20, 21, 46]. One potential mechanism is that Ubp2 antagonizes Rsp5-dependent 
ubiquitination, protecting adaptors or Rsp5 itself from proteosomal degradation [47]. Yet, Rsp5 
levels are not lower in ubp2∆ mutants [18] and triggering the pathways that use various adaptors 
such as Bul1, Bul2, Rim8, and Aly2 results in the generation of stably mono-ubiquitinated forms of 
the adaptors rather than generating intermediates for accelerated degradation [14, 15, 17]. 
Moreover, this does not explain how overexpressing Rsp5 in ubp2∆ cells can suppress the 
inhibitory effects on downregulation of membrane proteins (Figure 6D), since Rsp5 
overexpression should exacerbate the destruction of adaptor proteins. Additionally, we see no 
changes in the levels of Hua1 or Hua1K>R in wild-type vs ubp2∆ mutants (Figure 6E). Rather, we 
propose that a critical function of Ubp2 is to remove Ub from ubiquitinated adaptor proteins 
allowing them to cycle off Rsp5 more readily. Thus, in the absence of Ubp2, the availability of Rsp5 
for a wide range of adaptors would be restricted because the subset of ubiquitinated adaptors 
bound to Rsp5 would compete away the larger pool of adaptors more strongly. The prediction from 
this model is that the ability to compete for limited Rsp5 in ubp2∆ cells would show little difference 
between adaptors-fused to Ub that are resistant to deubiquitination versus wild-type adaptors that 
would be unable to undergo deubiquitination in the absence of Ubp2. This prediction was fulfilled 
in multiple experiments for both cognate and non-cognate substrates (Figs. 6, 7).  
 One of the implications from our observations and the model presented is that limited 
space on Rsp5 for its full set of adaptors and substrates enforces a level of coordinated regulation. 
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This could impart a ‘zero-sum game’ scenario where stimulating ubiquitination of a particular set of 
substrates, by recruitment and activation of a subset of Rsp5 adaptors, necessarily diminishes the 
capability of other adaptors to access Rsp5 and direct its activity to their cognate substrates. Not 
only does this explain how one ligase can regulate so many distinct substrates under constantly 
changing metabolic conditions, but this mechanism could be especially potent when large sets of 
adaptors are under coordinated control, such as glucose responsive AMP-kinase, nitrogen 
responsive TORC1 and its downstream Npr1, or calcium signaling through calcineurin that could 
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MAIN FIGURE LEGENDS 
 
Figure 1: Ubiquitination of Hua1 is required for its role in sorting cargo to the vacuole 
A) Schematic of Hua1 structure showing C-terminal zinc-finger (ZnF) domain, similar to Type I 
DnaJ proteins, and an N-terminal region that contains a [L/P]PxY interaction motif and 
ubiquitinated lysines, K3 and K18 (top) and function (bottom). The ESCRT apparatus sorts 
ubiquitinated membrane proteins into endosomal intralumenal vesicles. The E3 ligase Rsp5 
associates with the Ub-receptor complex ESCRT-0 component Hse1, both directly and indirectly 
via association with Hua1. A schematic of Hse1 is shown in Figure S1A. 
B) HA-epitope tagged Hua1 was expressed in cells from the CUP1 promoter with the addition of 
20 µM CuCl2 in cells expressing 6xHis-Ub. Ubiquitinated proteins were purified from a denatured 
lysate containing 8M urea over Ni-NTA agarose, eluted and immunoblotted for Ub (α-His) and 
Hua1 (α-HA). Both the HA-Hua1 and a slower migrating species of Hua1 corresponding to a 
mono-ubiquitinated form are observed in whole lysates, whereas only the latter was recovered 
from the Ni-NTA affinity column. 
C) The same procedure described in (B) was used to analyze ubiquitination of myc-epitope-tagged 
Hua1, V5-epitope-tagged Rim8, and HA-epitope-tagged Art1, all expressed from low-copy 
plasmids from the CUP1 promoter using 20µM CuCl2. Increased exposure of the relevant region of 
interest from the same acquisition is outlined in red.  
D) Levels of myc*-Hua1 and myc*-Hua1K>R (K3R, K18R) expressed at endogenous levels from the 
HUA1 promoter was by assessed by immunoblotting whole cell lysates. Insert shows over-
exposure of ubiquitinated species. The myc* epitope lacking lysine was EQRLISEEDL. Increased 
exposure of the relevant region of interest is outlined in red. These data are extended in Figure 
S1B,C. 
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E) Fluorescence microscopy of GFP-Cps1 in cells expressing the hse1∆rsp5 mutant alone or in 
combination with hua1∆ deletion (hua1∆ hse1∆rsp5) and co-expressing indicated forms of Hua1 
from low-copy plasmids under the endogenous HUA1 promoter.  
Scale bar, 5µM. 
 
Figure 2. Overexpressing Hua1 diminishes Rsp5-dependent functions 
A) Schematic of Hua1 proteins for overexpression including myc-tagged wild-type full-length 
protein (myc-Hua1), Ubiquitin (Ub)1-75 fused to the N-terminus of full-length Hua1 (myc-Ub-Hua1), 
and a truncation mutant lacking the first 20 residues (Hua1∆N). 
B) Levels of myc-tagged Hua1 proteins in (A) expressed from low copy plasmids under the control 
of the copper-inducible CUP1 promoter assessed by immunoblotting equal amounts of whole cell 
lysate, shown with α-CPY control, in cells grown in the presence of 50 µM CuCl2. Increased 
exposure (red) allows Ub bands to be visualized. Increased exposure of the relevant region of 
interest is outlined in red. (Additional uncropped exposures shown in Figure S1D). 
C) Growth of wild-type cells carrying the indicated Hua1 expression plasmids in the presence and 
absence of 50 µM CuCl2 at either 30°C or 37°C. Additional conditions grown in different CuCl2 
concentrations are shown in Figure S1E. 
D) Growth of wild-type cells carrying the Hua1, Hua1K>R expression plasmids, or vector control, in 
the presence and absence of 50 µM CuCl2 at either 30°C or 37°C. 
E) Vacuolar sorting of Sna3-GFP was assessed in wild-type (WT) cells expressing indicated Hua1 
plasmids. 
F) Cells expressing indicated myc tagged Hua1 plasmids were co-expressed with Sna3-HA and 
grown to late log phase to induce efficient vacuolar sorting before lysate generation and 
immuoblotting with indicated antibodies. Figure S2A shows same experiment with addition of CPY 
immunoblotting and Figure S2B shows results from different levels of CuCl2 induction. Below, 
quantitation of the relative levels of Sna3 and the proportion ubiqitinated was from separate 
experiments (examples shown in Figure S2C). The level of unmodified Sna3 was normalized CPY 
loading controls and compared to vector control cells; the proportion of ubiquitinated Sna3 was 
calculated by the ratio of Sna3 ubiquitinated bands vs total Sna3 and normalized to vector control 
(mean +/- SD, n=4).  
G) Sorting of GFP-Cps1, Gap1-GFP, Ste3-GFP, and Mup1-GFP in wild-type cells (Vector) or wild-
type cells expressing myc-tagged Hua1 plasmids and grown media containing 50 µM CuCl2. Cells 
expressing Mup1-GFP were grown in the presence of 20 µg/ml methionine for 1 hr prior to 
imaging. 
H) Cells expressing HA-Rim101 were grown to mid-log phase before shifting to buffer of indicated 
pH for 25 min at 30oC prior to immediate generation of lysates. HA-Rim101 processing was 
assessed by immunoblot from cells overexpressing Hua1 plasmids in the presence of 50 µM 
CuCl2, or co-transformed with a vector control plasmid. The effects of Hua1 overexpression in 
different strains and conditions is shown in Figure S3A,B. 
Scale bar, 5µM. 
 
Figure 3. Different adaptors compete for residency on Rsp5 
A) Schematic showing the ubiquitination of Mup1 via the cognate adaptor Art1, which is activated 
by its own ubiquitination. 
B) Mup1-GFP expressed in wild-type cells grown to mid-log phase was localized following over-
expression of indicated plasmids from the CUP1 promoter in the presence of 50 µM CuCl2. 
C) The levels of Art1-HA and Art1K>R-HA were assessed by immunoblot, with ubiquitinated species 
indicated (arrowhead). Figure S2D shows complementary data for monoubiquitiation of Art1-HA. 
D) Growth of WT cells expressing wild-type Art1 or Art1K>R(K466R) from the CUP1 promoter within 
low-copy plasmids or transformed with vector control. 
E) Schematic showing processing of Rim101 is mediated by the ubiquitination of Rim21 by its 
cognate adaptor Rim8, activity of which itself is regulated by ubiquitination and ligase residency. 
F) HA-Rim101 levels were assessed in buffered media in the presence of indicated variants of 
Rim8 over-expressed from the CUP1 promoter. 
G) Localization of GFP-Cps1 in wild-type cells at mid-log phase with over-expressed adaptors. 
Scale bar, 5µM. 
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Figure 4. Cycle of ubiquitination to control adaptor function 
Above are structural models (based on PDB: 4LCD and 3OLM) for the Rsp5 HECT domain 
interacting covalently and non-covalently with Ub. Highlighted is the position of F618, critical for 
Ub-binding. Below is a proposed model whereby different adaptors compete to occupy Rsp5. Initial 
binding of an adaptor results in its ubiquitination (1), which allows the ubiquitinated adaptor to bind 
tighter by also engaging the N-lobe Ubiquitin Binding Surface (UBS). This tight adaptor/Rsp5 
complex is now more dedicated towards the specific substrates targeted by the adaptor (2). To 
‘unlock’ ubiquitinated adaptors from Rsp5, Ubp2 is recruited to the complex via Rup1 and 
deubiquitinates adaptors (3), allowing them to disengage from Rsp5 and allow other adaptors to 
bind Rsp5 (4). 
 
Figure 5. Rsp5 levels suppress defects due to competing adaptors 
A) Growth of WT cells at 30°C and 37°C overexpressing Hua1 in the presence and absence of 
Rsp5 overexpression. Hua1 and HA-tagged Rsp5 were expressed from the CUP1 promoter with 
low copy plasmids in the presence and absence of 50 µM added CuCl2. 
B) Sorting of Ste3-GFP in WT cells grown in 30 µM CuCl2 expressing myc-Ub-Hua1 and/or HA-
Rsp5 from the CUP1 promoter within low-copy plasmids.  
C) Schematic rationale for the mating assay in (D). Once newly synthesized Ste3 is terminated by 
shifting cells to glucose, mating can only be sustained by residual cell-surface Ste3 which is 
constitutively downregulated by Rsp5. 
D) MATα his3 cells expressing Ste3-HA from the dextrose-repressible GAL1 promoter and 
expressing Ub-Hua1 under control of CUP1 promoter in presence of 50 µM copper were grown 
overnight in galactose media (GAL). Dextrose (DEX) was added or not for 20 min prior to mating 
with MATa his4 cells in rich media containing GAL or DEX. Cells were then pelleted, diluted, and 
spread on -His plates to select for diploid cells. The number of diploids from each plate were 
counted after 2 days growth and plotted. The GAL-STE3-HA MATα cells were also expressing 
either HA-Rsp5 or vector alone (*=p<0.05). Additional data using this assay are shown in Figure 
S3E. 
E) Growth of WT cells or cells carrying the rsp5∆Ub allele (F618A mutation blocking the N-lobe UBD) 
that were expressing myc-tagged Hua1, Ub-Hua1, or Hua1∆N from the CUP1 promoter within low-
copy plasmids. Growth was monitored at 30°C and 37°C in the presence and absence of added 
CuCl2 (50µM). 
F) Lysates from cells transformed with vector alone or that overexpressed myc-tagged Hua1, Ub-
Hua1, and Hua1∆N were immunoprecipitated with anti-myc polyclonal antibodies. Lysates (left) and 
immunoprecipitates (middle) were immunoblotted with polyclonal antibodies to Rsp5 or myc. Right 
shows quantitation of the ratio of Rsp5 to the level of immunoprecipitated Hua1 variant used 
calculated from 3 separate groups of transformants shown in Figure S3C (mean, +/-SD, n=3) anti-
GST-polyclonal antibodies and immunoblotted with anti-HA and anti-myc antibodies. HA-Rsp5 was 
expressed from RSP5 promoter, Hua1 variants were expressed from the CUP1 promoter. Below 
shows the relative ratio of HA:myc immunoreactivity within the myc-Hua1 immunoprecipitations.  
Scale bar, 5µM. Immunoprecipitation data using Rsp5 lacking its N-lobe Ub-binding surface is 
shown in Figure S3D. 
G) Hua1 and Ub-Hua1 were produced in bacteria as fusion proteins with GB1 that carried an C-
terminal HA tag. Lysates were mixed and incubated with beads coated with MBP alone (Ø) or a 
MBP-Rsp5 fusion protein. Beads were washed and immunoblotted with anti-HA along with a 10% 
equivalent of the pooled input lysate. 
 
Figure 6. Loss of Ubp2 increases potency of Hua1 as a competitive inhibitor 
A) Schematic of the complex Rsp5 forms with Rup1 and Ubp2. The 3 WW domains of Rsp5 
interact with PY motifs present in substrates and adaptors. Rup1, which has a PY motif, recruits 
the deubiquitinating enzyme Ubp2 to Rsp5. Areas sufficient for protein:protein interactions are 
indicated by horizontal line. Also cartooned are two bound Ub molecules within the catalytic HECT 
domain, one that is carried by the active site cysteine for transfer to substrates (red) and another 
bound non-covalently to the N-lobe UBD (blue). 
B) Growth of WT, ubp2∆ and ubp2∆ rup1∆ cells expressing myc-tagged Hua1 and Ub-Hua1 from 
the CUP1 promoter within low-copy plasmids at 30°C and 37°C in the presence and absence of 50 
µM CuCl2. 
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C) Sorting of Mup1-GFP in WT or ubp2∆ rup1∆ cells overexpressing myc-tagged Hua1, Ub-Hua1, 
and Hua1∆N. Cells were grown in SD media containing 50 µM CuCl2 and 20 µg/ml methionine for 
1hr. Representative micrographs are shown (left) with quantitation across multiple 
cells/experiments (right). Top quantitation shows percent of Mup1 at the cell surface individually for 
multiple cells along with the average value (line). Below quantitation shows the proportion of cells 
that showed the indicated schematic phenotype wherein methionine-induced downregulation was 
unperturbed and all cells showed Mup1 exclusively in the vacuole, vs defective downregulation 
where Mup1 was also observed in non-vacuolar compartments (cell surface and endosomes). 
Number (N) of WT cells counted expressing Hua1, Ub-Hua1, and Hua1∆N was 41,133,112. N for 
ubp2∆ rup1∆ cells was 177, 209, and 113, respectively. . Statistical significance for these levels 
are provided in Figure S4A. 
D) Sorting of GFP-Cps1 in wild-type and ubp2∆ cells in the presence and absence of 
overexpression of HA-Rsp5 from the CUP1 promoter in cells grown in 10 µM CuCl2. 
E) Immunoblot of WT, ubp2∆, and ubp2∆ rup1∆ cells expressing myc*-Hua1 and myc*-Hua1K>R 
from endogenous HUA1 promoter, with an Rsp5 immunoblot as loading control. An expanded 
dataset with quantitation is shown in Figure S4B. 
Scale bar, 5µM. 
 
Figure 7. Effects of competition and Ubp2 on adaptor cycling 
A) Schematic depicting the activity of ubiquitinated Art1 towards promoting downregulation of its 
cognate substrate Mup1 while also diminishing the activity other adaptors towards other cargoes 
that are not regulated by Art1 (left). Schematic depicting how ubiquitinated Rim8 will occupy Rsp5 
and inhibit the ability of Art1 to mediate ubiquitination and trafficking of Mup1 into the MVB 
pathway (right). In each case, adaptor cycling can be achieved through the enzymatic activity of 
Ubp2. 
B) Cells were imaged prior to (- Met) or following (+ Met) 1 h treatment with methionine. Mup1-
GFP was localized in WT (left) and ubp2∆ (right) cells grown to mid-log phase in the presence of 
indicated CUP1 over-expression plasmids. Quantitation of percent of Mup1 at the cell surface 
individually for multiple cells along with the average value (line) indicated (far right). Statistical 
significance for each comparison is summarized in Figure S4C. 
Scale bar, 5µM. 
C) Quantification of morphological profile for Mup1-GFP localization from data in (D) in the 
absence and presence of methionine. Left shows number of cells with exclusively cell surface 
distribution, distribution in endosomes, or distribution within the vacuole of cells grown in the 
absence of methionine and overexpressing the indicated forms of Art1. N=131,175,121,182 For 
Vector, Art1-HA, Art1-HA-Ub: N (WT) = 131,121,182, 175; N (ubp2∆) = 96,138,100.  
Middle shows number of cells with exclusively vacuolar localization (normal/ no effect) or defective 
localization with some in endosomes and cell surface after a 1hr treatment with methionine for 
cells overexpressing indicated Hua1 variants. Right shows cells with normal and defective 
distribution of Mup1 in cells overexpressing indicated variants of Rim8. For Vector, Rim8-V5, 
Rim8-V5K>R, Rim8-V5-Ub, myc-Hua1, myc-Hua1∆N, myc-Ub-Hua1: N(WT) = 








Lead Contact and Mateials Availability  
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by Robert Piper: robert-piper@uiowa.edu. All unique/stable reagents generated in this 
study are available from the Lead Contact without restriction. 
 
Experimental Model 
Studies were conducted in haploid strains of Saccharomyces cerevisiae.  Genotypes are 
described in Key Resource Table. Yeast cultures were grown in rich media (YPD: 2% glucose, 2% 
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peptone, 1% yeast extract) or minimal media (Synthetic Complete (SC) 2% glucose, 1x yeast 
nitrogen base; Research Products International, Mount Prospect, IL) with amino acid and base 
drop out compositions (Formedium, Norfolk, UK) for plasmid selection. Cells carrying plasmids 
expressing proteins from the CUP1 promoter were grown in liquid or solid agar containing 50 μM 
copper chloride unless otherwise stated. Yeast transformation was performed using the Lithium 
acetate method [48]. 
 
Fluorescence microscopy 
Yeast cultures expressing GFP tagged proteins were grown to mid-log phase (OD600 = 1.0), 
harvested and resuspended in “kill” buffer (100 mM Tris.HCl (pH 8.0), 0.2% (w/v) NaN3 and NaF) 
prior to imaging with an epifluorescence microscope (BX60; Olympus) with a 100x objective lens 
with numerical aperture (NA) 1.4. Images were captured with a cooled charge-coupled device 
camera (Orca R2; Hamamatsu Photonics) using iVision-Mac software (Biovision Technology). 
Image processing for display was performed in Photoshop. Image processing for quantitation was 
performed with Fiji. 
 
Viability assays 
Prior to viability assays performed on solid agar media yeast cells were grown to mid-log phase in 
appropriate selection media lacking extra CuCl2. OD600 measurements were used to harvest 
equivalent cell numbers from each culture, before cells were washed once with water and then 
diluted in a series of 10-fold dilution steps. 5-10µl of each dilution was then plated on SD media 
with and without CuCl2 and grown at 30°C or 37°C and growth was subsequently recorded 
following 24-48 hr incubation. 
 
Proteolytic processing of Rim101  
Rim101 experiments were typically performed in SEY6210 cells, unless otherwise stated, as the 
processing upon pH shift was more obvious than in BY4742 cells (as shown in Figure S2A). Cells 
were transformed with the LEU2 marked plasmid pFL1 expressing 3xHA-Rim101 and co-
transformed with either vector control or URA3 marked plasmids expressing either V5-Rim8 (and 
variants) as a cognate Rsp5 adaptor or myc-Hua1 (and variants) as a competing Rsp5 adaptor. 
Cells were grown to mid-log phase in SC-Ura-Leu media that was buffered to pH 5.5 with 50 mM 
MES (containing 50 µM CuCl2 to induce expression of adaptors). Cell densities were estimated 
across samples using OD600 measurements, before harvesting equivalent cell numbers for each 
condition. Each sample was split into 3 equal tubes, pelleted and brought up in buffer of either 100 
mM sodium citrate (pH = 3.5), 50 mM MES (pH = 5.5), or 50 mM MOPS (pH = 8.0) for 20 minutes 
before lysates were generated as described above. Samples were analysed by SDS-PAGE and 
immunoblotting with specific antibodies to appraise Rim101 species (anti-HA), levels of cognate 
Rim8 versions (anti-V5) and competing Hua1 versions (anti-myc), and loading controls (either anti-
Rsp5 or anti-PGK) 
 
Mating efficiency assay 
Strain PLY4804 was created by replacing the endogenous STE3 promoter region of wild-type 
BY4742 cells with a Kanamycin resistance cassette followed by the GAL1 promoter and an N-
terminal 3xHA epitope tag designed to replace the start methionine of the STE3 ORF. The strain 
was confirmed to express an HA-tagged version of Ste3 at the correct molecular weight when cells 
were grown in galactose (GAL) media, but expression was completely absent in the presence of 
dextrose (DEX). Importantly, the Matα BY4742 GAL1-3xHA-STE3 carries the his3∆ mutation. This 
meant that successful mating with PLY42, a Mata strain that carries wild-type HIS3 but is 
auxotrophic for histidine by virtue of the his4-519 mutation, could select for diploids in minimal 
media lacking histidine (SC-His). Mating reactions were first performed in cells growing in either 
glucose or galactose, with each strain grown to mid-log phase before 500µl of each being mixed 
and allowed to settled in a tube for 6 hours at 30oC in either GAL or DEX containing rich media. At 
least 4 different dilutions of cell mixtures were then made and plated on SC-His plates and grown 
at 30 degrees for 48 hours. Colonies were counted from each dilution and used to estimate how 
many successful diploids were generated from each condition. This basic assay was then used to 
perform additional experiments, including a glucose repression ‘pulse chase’ of Ste3 where GAL 
grown cells were split into two and incubated with either DEX or GAL for 20 minutes prior to the 
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mating assay as described. This pulse chase experiment was then performed in minimal media in 
cells expressing URA3 borne Hua1 constructs, grown in the presence of 50 µM CuCl2 or cells 
expressing Ub-Hua1 with either HA-Rsp5 or a vector control. Average His+ diploids for each 
experimental condition were calculated with the standard deviation shown with error bars. 
 
Immunoprecipitation & Immunodetection 
For whole-cell lysates, yeast cells were pelleted and first resuspended in 0.2 N NaOH for two 
minutes. Laemmli sample buffer containing 8 M urea was added (75 mM Tris [pH 6.8], 8 M urea, 
3% SDS with bromophenol blue), and lysates resolved by SDS-PAGE, transferred to 
nitrocellulose, and analysed by blotting with the indicated antibodies. For co-immunoprecipitation 
experiments cells transformed with copper inducible myc-tagged Hua1 constructs. Cells were 
grown to mid-log phase in 25 μM CuCl2, harvested, washed and resuspended in lysis buffer (PBS 
and protease inhibitor cocktail) and lysed using the One-shot instrument from Constant Systems, 
Ltd.. Cell debris was removed by centrifugation and the supernatant (‘Input’) incubated with 
polyclonal goat anti-myc antibodies conjugated to sepharose for 90 min on ice.  After washing 3 
times with lysis buffer containing 0.1% Tween-20, bound proteins were eluted from the beads 
using Laemmli sample buffer, followed by standard immunoblotting procedures (described above) 
using anti-HA and anti-myc monoclonal antibodies. Antibodies and antibody-based reagents are 
further described in the key resource table. 
 
Isolation of ubiquitinated proteins 
Strain PLY4272 was optimized for purification of ubiquitinated proteins by replacing the UBI4 gene 
with a His6 tagged version of Ubiquitin, separated by a short 8 amino acid linker (ALINQERA) and 
expressed from a low level constitutive promoter (a mutant form of the TEF1 promoter (Nevoigt et 
al., 2006). Hbt1 is a significant contaminant to His6-tag purifications from yeast cell lysates 
(MacDonald et al., 2017), so the chromosomal HBT1 ORF was modified to truncate the C terminus 
encoding a histidine rich region (amino acids 967-1049). PLY4272 also lacks the PDR5 gene. A 
large (2 Litre) culture of PLY4272 cells was prepared from single colony transformants expressing 
either HA-tagged Hua1, myc-Hua1, Art1-HA and Rim8-V5  were grown to mid-log phase, 
harvested, treated for 3 min with 0.2 N NaOH prior to lysates being generated in denaturing buffer 
containing 2.5% SDS and 8 M urea. Cells were then diluted 20-fold in binding buffer (50 mM 
Tris.HCl pH 8.0, 8 M urea, 10% (w/v) glycerol, 5 mM β-Me), incubated for 2 hrs at room 
temperature with 3 ml (50% slurry) Ni2+-NTA agarose and collected in a column. Beads were 
washed with 10 x with binding buffer containing 10 mM imidazole and bound proteins eluted using 
10ml binding buffer with pH shifted to 4.5. These eluates were rebound to a small volume of (300-
400 µl) 50% slurry Ni2+-NTA agarose for a further 2 hrs at room temperature. Beads were then 
harvested in a column and washed 10 x with binding buffer containing 10 mM imidazole and then 
eluted in 1 ml buffer containing 350 mM imidazole. Original lysates and purified eluates containing 
ubiquitinated proteins were resuspended in Laemmli sample buffer [49], resolved by SDS-PAGE, 
transferred to nitrocellulose and immunoblotted with antibodies raised against the specific epitope 
of each fusion protein, as described above. 
 
Quantification and statistical analysis 
To quantify the percentage of Mup1-GFP at the cell surface, matched DIC and green fluorescence 
images were aligned using the Registration/Align function within Fiji [50]. Segmentation was 
performed on the DIC image using the Cell Magic Wand plugin (Min = 8, Max = 300, roughness = 
2.0) to define a region of interest for the whole cell (R1) to which a negative expansion was applied 
to achieve a morphological transformation for a smaller region of interest lacking signal from the 
plasma membrane (R2). Following background subtraction, the percentage Mup1-GFP at the 
surface was given by R1-R2/R1*100. A series of smaller regions of interest were generated by 
sequential negative expansions, and the lowest mean intensity value across this set was taken as 
the level of background. To quantify the overall distribution localization profiles, cells were scored 
qualitatively for either having fluorescence exclusively, partially, or not detectable at the cell 
surface and whether fluorescence was found exclusively or partially within endosomal puncta or 




Data Code and Availability  
The published article includes all data generated or analyzed during this study with the exception 
of raw micrographs analysed for Figures 6 and 7. 
Data for quantitation in Figures 6 and 7 have not been deposited in a public repository because 
they were too numerous and exemplified in representative micrographs and presented in graphed 
format.  They are available from the corresponding author on request. 
 
Table S1. The exact yeast strains, antibodies, and plasmids used for each figure are listed in in an 








1. Rotin, D., and Kumar, S. (2009). Physiological functions of the HECT family of ubiquitin 
ligases. Nat Rev Mol Cell Biol 10, 398-409. 
2. Piper, R.C., Dikic, I., and Lukacs, G.L. (2014). Ubiquitin-dependent sorting in endocytosis. 
Cold Spring Harbor perspectives in biology 6. 
3. Lu, K., Yin, X., Weng, T., Xi, S., Li, L., Xing, G., Cheng, X., Yang, X., Zhang, L., and He, F. 
(2008). Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation 
by CKIP-1. Nat Cell Biol 10, 994-1002. 
4. Lauwers, E., Erpapazoglou, Z., Haguenauer-Tsapis, R., and Andre, B. (2010). The ubiquitin 
code of yeast permease trafficking. Trends Cell Biol 20, 196-204. 
5. Leon, S., and Haguenauer-Tsapis, R. (2009). Ubiquitin ligase adaptors: regulators of 
ubiquitylation and endocytosis of plasma membrane proteins. Exp Cell Res 315, 1574-
1583. 
6. Shearwin-Whyatt, L., Dalton, H.E., Foot, N., and Kumar, S. (2006). Regulation of functional 
diversity within the Nedd4 family by accessory and adaptor proteins. Bioessays 28, 617-
628. 
7. Hettema, E.H., Valdez-Taubas, J., and Pelham, H.R. (2004). Bsd2 binds the ubiquitin 
ligase Rsp5 and mediates the ubiquitination of transmembrane proteins. EMBO J 23, 1279-
1288. 
8. Leon, S., Erpapazoglou, Z., and Haguenauer-Tsapis, R. (2008). Ear1p and Ssh4p are new 
adaptors of the ubiquitin ligase Rsp5p for cargo ubiquitylation and sorting at multivesicular 
bodies. Mol Biol Cell 19, 2379-2388. 
9. Lin, C.H., MacGurn, J.A., Chu, T., Stefan, C.J., and Emr, S.D. (2008). Arrestin-related 
ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. Cell 
135, 714-725. 
10. MacDonald, C., Stringer, D.K., and Piper, R.C. (2012). Sna3 Is an Rsp5 Adaptor Protein 
that Relies on Ubiquitination for Its MVB Sorting. Traffic. 
11. Nikko, E., and Pelham, H.R. (2009). Arrestin-mediated endocytosis of yeast plasma 
membrane transporters. Traffic 10, 1856-1867. 
12. Nikko, E., Sullivan, J.A., and Pelham, H.R. (2008). Arrestin-like proteins mediate 
ubiquitination and endocytosis of the yeast metal transporter Smf1. EMBO Rep 9, 1216-
1221. 
13. Kee, Y., Munoz, W., Lyon, N., and Huibregtse, J.M. (2006). The deubiquitinating enzyme 
Ubp2 modulates Rsp5-dependent Lys63-linked polyubiquitin conjugates in Saccharomyces 
cerevisiae. J Biol Chem 281, 36724-36731. 
14. Merhi, A., and Andre, B. (2012). Internal amino acids promote Gap1 permease 
ubiquitylation via TORC1/Npr1/14-3-3-dependent control of the Bul arrestin-like adaptors. 
Mol Cell Biol 32, 4510-4522. 
15. Hatakeyama, R., Kamiya, M., Takahara, T., and Maeda, T. (2010). Endocytosis of the 
aspartic acid/glutamic acid transporter Dip5 is triggered by substrate-dependent recruitment 
of the Rsp5 ubiquitin ligase via the arrestin-like protein Aly2. Mol Cell Biol 30, 5598-5607. 
 15 
16. Becuwe, M., Vieira, N., Lara, D., Gomes-Rezende, J., Soares-Cunha, C., Casal, M., 
Haguenauer-Tsapis, R., Vincent, O., Paiva, S., and Leon, S. (2012). A molecular switch on 
an arrestin-like protein relays glucose signaling to transporter endocytosis. J Cell Biol 196, 
247-259. 
17. Herrador, A., Herranz, S., Lara, D., and Vincent, O. (2010). Recruitment of the ESCRT 
machinery to a putative seven-transmembrane-domain receptor is mediated by an arrestin-
related protein. Mol Cell Biol 30, 897-907. 
18. Kee, Y., Lyon, N., and Huibregtse, J.M. (2005). The Rsp5 ubiquitin ligase is coupled to and 
antagonized by the Ubp2 deubiquitinating enzyme. EMBO J 24, 2414-2424. 
19. Lam, M.H., and Emili, A. (2013). Ubp2 regulates Rsp5 ubiquitination activity in vivo and in 
vitro. PLoS One 8, e75372. 
20. Lam, M.H., Urban-Grimal, D., Bugnicourt, A., Greenblatt, J.F., Haguenauer-Tsapis, R., and 
Emili, A. (2009). Interaction of the deubiquitinating enzyme Ubp2 and the e3 ligase Rsp5 is 
required for transporter/receptor sorting in the multivesicular body pathway. PLoS One 4, 
e4259. 
21. Ren, J., Kee, Y., Huibregtse, J.M., and Piper, R.C. (2007). Hse1, a component of the yeast 
Hrs-STAM ubiquitin-sorting complex, associates with ubiquitin peptidases and a ligase to 
control sorting efficiency into multivesicular bodies. Mol Biol Cell 18, 324-335. 
22. Erpapazoglou, Z., Dhaoui, M., Pantazopoulou, M., Giordano, F., Mari, M., Leon, S., 
Raposo, G., Reggiori, F., and Haguenauer-Tsapis, R. (2012). A dual role for K63-linked 
ubiquitin chains in multivesicular body biogenesis and cargo sorting. Mol Biol Cell 23, 2170-
2183. 
23. French, M.E., Kretzmann, B.R., and Hicke, L. (2009). Regulation of the RSP5 ubiquitin 
ligase by an intrinsic ubiquitin-binding site. J Biol Chem 284, 12071-12079. 
24. Kim, H.C., Steffen, A.M., Oldham, M.L., Chen, J., and Huibregtse, J.M. (2011). Structure 
and function of a HECT domain ubiquitin-binding site. EMBO Rep 12, 334-341. 
25. Maspero, E., Mari, S., Valentini, E., Musacchio, A., Fish, A., Pasqualato, S., and Polo, S. 
(2011). Structure of the HECT:ubiquitin complex and its role in ubiquitin chain elongation. 
EMBO Rep 12, 342-349. 
26. Ogunjimi, A.A., Wiesner, S., Briant, D.J., Varelas, X., Sicheri, F., Forman-Kay, J., and 
Wrana, J.L. (2010). The ubiquitin binding region of the Smurf HECT domain facilitates 
polyubiquitylation and binding of ubiquitylated substrates. J Biol Chem 285, 6308-6315. 
27. Lee, J.R., Oestreich, A.J., Payne, J.A., Gunawan, M.S., Norgan, A.P., and Katzmann, D.J. 
(2009). The HECT domain of the ubiquitin ligase Rsp5 contributes to substrate recognition. 
J Biol Chem 284, 32126-32137. 
28. Fang, N.N., Chan, G.T., Zhu, M., Comyn, S.A., Persaud, A., Deshaies, R.J., Rotin, D., 
Gsponer, J., and Mayor, T. (2014). Rsp5/Nedd4 is the main ubiquitin ligase that targets 
cytosolic misfolded proteins following heat stress. Nat Cell Biol 16, 1227-1237. 
29. Peng, J., Schwartz, D., Elias, J.E., Thoreen, C.C., Cheng, D., Marsischky, G., Roelofs, J., 
Finley, D., and Gygi, S.P. (2003). A proteomics approach to understanding protein 
ubiquitination. Nature biotechnology 21, 921-926. 
30. Hervas-Aguilar, A., Galindo, A., and Penalva, M.A. (2010). Receptor-independent Ambient 
pH signaling by ubiquitin attachment to fungal arrestin-like PalF. J Biol Chem 285, 18095-
18102. 
31. Hovsepian, J., Defenouillere, Q., Albanese, V., Vachova, L., Garcia, C., Palkova, Z., and 
Leon, S. (2017). Multilevel regulation of an alpha-arrestin by glucose depletion controls 
hexose transporter endocytosis. J Cell Biol 216, 1811-1831. 
32. Herrador, A., Leon, S., Haguenauer-Tsapis, R., and Vincent, O. (2013). A mechanism for 
protein monoubiquitination dependent on a trans-acting ubiquitin-binding domain. J Biol 
Chem 288, 16206-16211. 
33. Hiraki, T., and Abe, F. (2010). Overexpression of Sna3 stabilizes tryptophan permease 
Tat2, potentially competing for the WW domain of Rsp5 ubiquitin ligase with its binding 
protein Bul1. FEBS Lett 584, 55-60. 
34. O'Donnell, A.F., Apffel, A., Gardner, R.G., and Cyert, M.S. (2010). Alpha-arrestins Aly1 and 
Aly2 regulate intracellular trafficking in response to nutrient signaling. Mol Biol Cell 21, 
3552-3566. 
 16 
35. MacDonald, C., Stringer, D.K., and Piper, R.C. (2012). Sna3 is an Rsp5 adaptor protein 
that relies on ubiquitination for its MVB sorting. Traffic 13, 586-598. 
36. Reggiori, F., and Pelham, H.R. (2001). Sorting of proteins into multivesicular bodies: 
ubiquitin-dependent and -independent targeting. EMBO J 20, 5176-5186. 
37. Penalva, M.A., Lucena-Agell, D., and Arst, H.N., Jr. (2014). Liaison alcaline: Pals entice 
non-endosomal ESCRTs to the plasma membrane for pH signaling. Curr Opin Microbiol 22, 
49-59. 
38. Kota, J., Melin-Larsson, M., Ljungdahl, P.O., and Forsberg, H. (2007). Ssh4, Rcr2 and Rcr1 
affect plasma membrane transporter activity in Saccharomyces cerevisiae. Genetics 175, 
1681-1694. 
39. Hiraki, T., Usui, K., and Abe, F. (2010). Overexpression of EAR1 and SSH4 that encode 
PPxY proteins in the multivesicular body provides stability to tryptophan permease Tat2, 
allowing yeast cells to grow under high hydrostatic pressure. High Pressure Research 30, 
514-518. 
40. French, M.E., Klosowiak, J.L., Aslanian, A., Reed, S.I., Yates, J.R., 3rd, and Hunter, T. 
(2017). Mechanism of ubiquitin chain synthesis employed by a HECT domain ubiquitin 
ligase. J Biol Chem 292, 10398-10413. 
41. Davis, N.G., Horecka, J.L., and Sprague, G.F., Jr. (1993). Cis- and trans-acting functions 
required for endocytosis of the yeast pheromone receptors. J Cell Biol 122, 53-65. 
42. Helliwell, S.B., Losko, S., and Kaiser, C.A. (2001). Components of a ubiquitin ligase 
complex specify polyubiquitination and intracellular trafficking of the general amino acid 
permease. J Cell Biol 153, 649-662. 
43. Novoselova, T.V., Zahira, K., Rose, R.S., and Sullivan, J.A. (2012). Bul proteins, a 
nonredundant, antagonistic family of ubiquitin ligase regulatory proteins. Eukaryot Cell 11, 
463-470. 
44. Stringer, D.K., and Piper, R.C. (2011). A single ubiquitin is sufficient for cargo protein entry 
into MVBs in the absence of ESCRT ubiquitination. J Cell Biol 192, 229-242. 
45. Attali, I., Tobelaim, W.S., Persaud, A., Motamedchaboki, K., Simpson-Lavy, K.J., 
Mashahreh, B., Levin-Kravets, O., Keren-Kaplan, T., Pilzer, I., Kupiec, M., et al. (2017). 
Ubiquitylation-dependent oligomerization regulates activity of Nedd4 ligases. EMBO J 36, 
425-440. 
46. Fang, N.N., Zhu, M., Rose, A., Wu, K.P., and Mayor, T. (2016). Deubiquitinase activity is 
required for the proteasomal degradation of misfolded cytosolic proteins upon heat-stress. 
Nat Commun 7, 12907. 
47. Ho, H.C., MacGurn, J.A., and Emr, S.D. (2017). Deubiquitinating enzymes Ubp2 and 
Ubp15 regulate endocytosis by limiting ubiquitination and degradation of ARTs. Mol Biol 
Cell 28, 1271-1283. 
48. Gietz, R.D., Schiestl, R.H., Willems, A.R., and Woods, R.A. (1995). Studies on the 
transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11, 355-
360. 
49. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227, 680-685. 
50. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., 
Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012). Fiji: an open-source 
platform for biological-image analysis. Nat Methods 9, 676-682. 
51. Stamenova, S.D., Dunn, R., Adler, A.S., and Hicke, L. (2004). The Rsp5 ubiquitin ligase 
binds to and ubiquitinates members of the yeast CIN85-endophilin complex, Sla1-Rvs167. 
J Biol Chem 279, 16017-16025. 
52. Richardson, S.C., Winistorfer, S.C., Poupon, V., Luzio, J.P., and Piper, R.C. (2004). 
Mammalian late vacuole protein sorting orthologues participate in early endosomal fusion 
and interact with the cytoskeleton. Mol Biol Cell 15, 1197-1210. 
53. Casadaban, M.J., and Cohen, S.N. (1980). Analysis of gene control signals by DNA fusion 
and cloning in Escherichia coli. J Mol Biol 138, 179-207. 
54. Brachmann, C.B., Davies, A., Cost, G.J., Caputo, E., Li, J., Hieter, P., and Boeke, J.D. 
(1998). Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful 
set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 
14, 115-132. 
 17 
55. Robinson, J.S., Klionsky, D.J., Banta, L.M., and Emr, S.D. (1988). Protein sorting in 
Saccharomyces cerevisiae: isolation of mutants defective in the delivery and processing of 
multiple vacuolar hydrolases. Mol Cell Biol 8, 4936-4948. 
56. MacDonald, C., Winistorfer, S., Pope, R.M., Wright, M.E., and Piper, R.C. (2017). Enzyme 
reversal to explore the function of yeast E3 ubiquitin-ligases. Traffic 18, 465-484. 
57. MacDonald, C., Buchkovich, N.J., Stringer, D.K., Emr, S.D., and Piper, R.C. (2012). Cargo 
ubiquitination is essential for multivesicular body intralumenal vesicle formation. EMBO Rep 
13, 331-338. 
58. Rothman, J.H., Howald, I., and Stevens, T.H. (1989). Characterization of genes required for 
protein sorting and vacuolar function in the yeast Saccharomyces cerevisiae. EMBO J 8, 
2057-2065. 
59. Dunn, R., and Hicke, L. (2001). Domains of the Rsp5 ubiquitin-protein ligase required for 
receptor-mediated and fluid-phase endocytosis. Mol Biol Cell 12, 421-435. 
60. Gerhard, W., Yewdell, J., Frankel, M.E., and Webster, R. (1981). Antigenic structure of 
influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290, 713-717. 
61. Evan, G.I., Lewis, G.K., Ramsay, G., and Bishop, J.M. (1985). Isolation of monoclonal 
antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 5, 3610-3616. 
62. Golnik, R., Lehmann, A., Kloetzel, P.M., and Ebstein, F. (2016). Major Histocompatibility 
Complex (MHC) Class I Processing of the NY-ESO-1 Antigen Is Regulated by Rpn10 and 
Rpn13 Proteins and Immunoproteasomes following Non-lysine Ubiquitination. J Biol Chem 
291, 8805-8815. 
63. Christensen, N.D., Dillner, J., Eklund, C., Carter, J.J., Wipf, G.C., Reed, C.A., Cladel, N.M., 
and Galloway, D.A. (1996). Surface conformational and linear epitopes on HPV-16 and 
HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 223, 174-184. 
64. Crowe, J., Dobeli, H., Gentz, R., Hochuli, E., Stuber, D., and Henco, K. (1994). 6xHis-Ni-
NTA chromatography as a superior technique in recombinant protein 
expression/purification. Methods Mol Biol 31, 371-387. 
65. Sikorski, R.S., and Hieter, P. (1989). A system of shuttle vectors and yeast host strains 
designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122, 19-
27. 
66. Odorizzi, G., Babst, M., and Emr, S.D. (1998). Fab1p PtdIns(3)P 5-kinase function 
essential for protein sorting in the multivesicular body. Cell 95, 847-858. 
67. Urbanowski, J.L., and Piper, R.C. (1999). The iron transporter Fth1p forms a complex with 
the Fet5 iron oxidase and resides on the vacuolar membrane. J Biol Chem 274, 38061-
38070. 
68. Hayashi, M., Fukuzawa, T., Sorimachi, H., and Maeda, T. (2005). Constitutive activation of 
the pH-responsive Rim101 pathway in yeast mutants defective in late steps of the 
MVB/ESCRT pathway. Mol Cell Biol 25, 9478-9490. 
69. Gajewska, B., Kaminska, J., Jesionowska, A., Martin, N.C., Hopper, A.K., and Zoladek, T. 
(2001). WW domains of Rsp5p define different functions: determination of roles in fluid 






Key resource table: 
 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
α-HA. Mouse Monoclonal (HA.11).   Biolegend, SanDiego, CA Cat# HA.11 
α-myc. Rabbit Polyclonal.  QED Biosciences Inc., San 
Diego, CA 
Cat# 18826 
α-myc. Mouse Monoclonal (THETM-myc Tag). Genscript, Piscataway, NJ Cat# A00704 
α-6xHis. Mouse Monoclonal (THETM-His Tag).   Genscript, Piscataway, NJ Cat# A00174-40 
α-PGK. Mouse Monoclonal Molecular Probes Cat# 459250 
α-V5.  Mouse Monoclonal.   Invitrogen, ThermoFisher Cat# R960-25 
α-CPY.  Mouse Monoclonal antibody (10A5-B5) Invitrogen, ThermoFisher Cat# A-6428 
α-Rsp5.  Rabbit Polyclonal antibody [51]  
α-GST.  Rabbit Polyclonal antibody [52]  
α-myc.  Goat Polyclonal antibody conjugated to sepharose QED Biosciences Inc., San 
Diego, CA 
Cat# 18824A 
Bacterial and Virus Strains  
BL21 (DE3) E. coli. fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS λ DE3 = λ sBamHIo 
∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 New England Biolabs, MA Cat# C2527H 
MC1061 E. coli. araD139 Del(araA-leu)7697 Del(lac)X74 galK16 galE15(GalS) 
lambda- e14- mcrA0 relA1 rpsL150(strR) spoT1 mcrB1 hsdR2 
[53]  
   
Biological Samples   
No critical biological samples   
Chemicals, Peptides, and Recombinant Proteins 
Peptone RPI, Mt Prospect, IL Cat# P200248 
Yeast Extract RPI, Mt Prospect, IL Cat# Y20020 
Tryptone RPI, Mt Prospect, IL Cat# T60060 
Yeast Nitrogen Base RPI, Mt Prospect, IL Cat# Y20040 
Dextose RPI, Mt Prospect, IL Cat# G32045 
NaCl RPI, Mt Prospect, IL Cat# S23025 
Urea RPI, Mt Prospect, IL Cat#U20200 
Bacto Agar Becton Dickenson, Sparks MD Cat# 214010 
Amino Acid supplements Formedium, Hunstanton, UK  Custom 
Galactose Sigma, St. Louis, MO Cat# G0625 
Complete Protease Inhibitor Sigma, St. Louis, MO 
Cat# 11697498001 
 
   
Critical Commercial Assays 
     No critical commercial assays   
Deposited Data 
     No other datasets   
Experimental Models: Cell Lines 
     None   
Experimental Models: Organisms/Strains 
(PLY1877) BY4742 Wild-type; MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 [54] N/A 
(PLY355) SEY6210 Wild-type; MAT, leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 
lys2-801 suc2-Δ9 [55] N/A 
(PLY4272) BY4742; pdr5∆::loxP hbt1∆C::loxP                                                 
ubi4∆::TEF1*-6xHis-ALINQERA-Ub-his5+ [56] N/A 
(PLY3173) BY4742; hse1∆rsp5::HIS3 (P(445)PPGYEQ>AAAGYEQ) [21] N/A 
Key Resource Table
(PLY3469) BY4742; hua1Δ::kanr hse1∆rsp5::HIS3 This manuscript N/A 
(PLY2463) SEY6210; pep4∆ [57] N/A 
(PLY4804) STE3-5’UTR∆::kanr-GAL1-3xHA-Ste3  This manuscript N/A 
(PLY42) SF838-9Da Wild-type MATa leu2-3,112, ura3-52, his4-519, ade6 [58] N/A 
(PLY4072) his3 leu2 ura3 trp1 bar1 rsp5∆::HIS3 with pRsp5-TRP1 plasmid 
(LHW1103) 
[59] N/A 
(PLY4074) his3 leu2 ura3 trp1 bar1 rsp5∆::HIS3 with pRsp5-F618A-TRP1 plasmid 
(LHY2737) 
[23] N/A 
(PLY3923) ubp2∆::kanr This manuscript N/A 
(PLY3927) ubp2∆::kanr rup1∆::his5+ This manuscript N/A 
(PLY5709) rup1∆::kanr This manuscript N/A 
(PLY4151) hua1∆::kanr [21] N/A 
   
Oligonucleotides   
There are no oligonucleotides critical for the reproduction of these experiments   
   
Recombinant DNA    
HA epitope tag = YPYDVPDYA [60] N/A 
myc epitope tag = EQKLISEEDL [61] N/A 
myc* epitope tag = EQRLISEEDL [62] N/A 
V5 epitope tag = GKPIPNPLLGLDST [63] N/A 
His tag = HHHHHH [64] N/A 




(pPL82) URA3 containing low copy CEN plasmid (pRS316) [65] N/A 
(pPL83) LEU2 containing low copy CEN plasmid (pRS315) [65] N/A 
(pPL138) HIS3 containing low copy CEN plasmid (pRS313) [65] N/A 
(pPL4418) pRS316 expressing 3xHA-Hua1 from TEF1 promoter This manuscript N/A 
(pPL4390) pRS316 expressing myc-Hua1 from CUP1 promoter This manuscript N/A 
(pPL6419) pRS316 expressing Rim8-3xV5 from CUP1 promoter This manuscript N/A 
(pPL5468) pRS316 expressing myc*-Hua1 from HUA1 promoter This manuscript N/A 
(pPL5467) pRS316 expressing myc*-Hua1K>R(K3R K18R) from HUA1 promoter This manuscript N/A 
(pPL1857) pRS16 expressing GFP-Cps1 from PRC1 promoter (pGO45) [66] N/A 
(pPL4392) pRS316 expressing Ub-myc-Hua1 from CUP1 promoter This manuscript N/A 
(pPL4394) pRS316 expressing myc-Hua1∆N (Hua1 21-198) from CUP1 promoter This manuscript N/A 
(pPL2089) pRS315 expressing Sna3-GFP fromSNA3 promoter [35] N/A 
(pPL6151) pRS315 expressing Sna3-2xHA from SNA3  promoter This manuscript N/A 
(pPL2572) pRS315 expressing GFP-Cps1 from PRC1  promoter This manuscript N/A 
(pPL967) pRS315 expressing Ste3-GFP from STE3 promoter [67] N/A 
(pPL2334) pRS315 expressing Gap1-GFP from CUP1 promoter [44] N/A 
(pPL4069) pRS315 expressing Mup1-GFP from MUP1 promoter [44] N/A 
(pPL3109). pRS315 expressing 3xHA-Rim101 from ???? promoter (pFL1) [68]  N/A 
(pPL6419) pRS316 expressing Rim8-3xV5 from CUP1 promoter This manuscript N/A 
(pPL6462) pRS316 expressing Rim8-3xV5-Ub from CUP1 promoter This manuscript N/A 
(pPL6414) pRS316 expressing Rim8-3xV5K>R(K521R) from CUP1 promoter This manuscript N/A 
(pPL6413) pRS316 expressing Rim8-3xV5K>R(K521R)-Ub from CUP1 promoter This manuscript N/A 
(pPL5081) pRS315 expressing 3xHA-Rsp5 from CUP1 promoter This manuscript N/A 
(pPL991) pRS313 expressing Ste3-GFP from STE3 promoter [44] N/A 
(p5642) YCplac33 expressing HA-Rsp5 from RSP5 promoter [69] N/A 
(p5797) pET28MBP expressing 6xHis-MBP-Rsp5 from T7 promoter (pJL242) [27] N/A 
(pPL6374) pET21a expressing Hua1-GB1-HA-6xHis from T7 promoter This manuscript N/A 
(pPL6373) pET21a expressing Ub-Hua1-GB1-HA-6xHis from T7 promoter This manuscript N/A 
(pPL4626) pRS316 expressing myc*-Hua1 from CUP1 promoter This manuscript N/A 
(pPL4628) pRS316 expressing myc*-Hua1K>R from CUP1 promoter This manuscript N/A 
pMAL.  Maltose-binding protein expression plasmid New England Biolabs, MA Cat# E8200S 
   
Software and Algorithms 






Microsoft Office.  Microsoft 
https://www.office.c
om 
Lasergene.  DNAstar 
https://www.dnastar
.com/software/ 
Pymol.  Schrödinger https://pymol.org/2/ 
Fiji 
Eliceiri/LOCI group University 
of Wisconsin-Madison 
https://fiji.sc 




   
Other   
One-Shot, cell disruptor 
Constant Systems Ltd  































































































Figure S1. Characterization and phenotypic effects of adaptor ubiquitination 
Related to Figure 1.  It shows architecture of Hse1, shows more  evidence for ubiquitination of 
Hua1, and shows effects on growth when Hua1 is overexpressed. 
a) Schematic depicting the domain structure of Hse1, including the Vps27, Hrs, and STAM (VHS) 
domain, Ubiquitin Interacting Motif (UIM), Src homology-3 domain (SH3) regions. The C-terminal 
residues of wild-type Hse1 (QPPPGYEQ) are also shown, including the mutated sequence 
(QAAAGYEQ) that disrupts the interaction of Hse1 with Rsp5 (Hse1∆Rsp5). 
b) Left, cartoon of the reverse gradient discontinuous gel strategy to better separate unmodified 
Hua1 from the very small portion of ubiquitinated Hua1 found in whole cell lysates. Proteins 
samples that transition from the stack (4%, pH 6.8) are sequentially resolved on separating gels of 
15%, then 12%, then 10% (all pH = 8.8) to increase distance between small and large proteins. 
Right, lysates from 3 distinct single colony wild-type transformants expressing either myc-Hua1 or 
Ub-myc-Hua1 from the CUP1 promoter (in the presence of 50 µM CuCl2) were resolved on the 
gradient gels described and immunoblotted using anti-myc antibodies. The ubiquitinated Hua1 
species, that run at the same size as Ub-Hua1 band (red arrowhead), can be clearly distinguished 
from the unmodified species (black arrow head), particularly with an increased exposure of the blot 
(bottom, red outline). 
c) Levels of myc*-Hua1 and myc*-Hua1K>R expressed from the endogenous HUA1 promoter were 
assessed in hua1∆, hse1∆Rsp5, and hua1∆ hse1∆Rsp5 by immunoblotting lysates generated from 
cells grown to mid-log stage before processing. The position of ubiquitinated Hua1 is designated 
with red arrowhead. 
d) Data summarized in Figure 2B showing longer exposures to better reveal ubiquitinated bands 
for myc-Hua1 and myc-Ub-Hua1. 
e) Wild-type cells expressing Hua1 or mutant versions were grown to mid-log phase for 6 hrs 
before harvesting and serial dilution (10-fold) in water. Each dilution was spotted onto minimal 
media agar plates lacking uracil to select for Hua1 plasmids or vector control, and containing 








Figure S2. Characterization and phenotypic effects of adaptor ubiquitination 
Related to main Figure 2 to further show that overexpression of Hua1 stabilizes Sna3. This is also 
related to Figure 3 showing ubiquitination of Art1. 
a) Extension of data in Figure 2F including anti-CPY immunoblot control. 
b) Wild-type cells expressing Sna3-HA and carrying the indicated expression plasmids were grown 
in the presence of the indicated concentrations of CuCl2 (0 µM – 50 µM).  Lysates were analyzed 
by immunoblotting with α-myc, ⍺-HA, and α-Rsp5 antibodies.  Immunoblots with increased 
exposure (red outline) reveal ubiquitinated species of Sna3-HA (red arrowheads). An SDS-
resistant dimeric species of Sna3-HA is also indicated (grey arrowheads). 
c) Wild-type cells expressing Sna3-HA and carrying the indicated epression plasmids were  grown 
in 20µM CuCl2 to an optical density of 0.8 or 1.6. before lysis and immunoblotting.  Immunoblots 
with increased exposure (red outline) reveal ubiquitinated species of Sna3-HA (red arrowheads). 
An SDS-resistant dimeric species of Sna3-HA is also indicated (grey arrowheads). 
d) Wild-type cells transformed with plasmids producing Art1-HA-Ub, Art1-HA and Art1K>R-HA under 
the control of the CUP1 promoter were grown to mid-log phase and pulsed with 20µM CuCl2 for 2 
hrs before harvesting and generation of whole cell lysates. The levels of unmodified and 






Figure S3. Characterization and phenotypic effects of adaptor ubiquitination 
Related to Figure 5 by showing expanded dataset containing co-immunoprecipitation data of Rsp5 
with Hua1, effect of Hua1 and Rim8 overexpression of Rim101 processing, and additional data on 
the effects on Ste3 downregulation using the mating assay in main Figure 5. 
a) Comparison of myc-Hua1, Ub-myc-Hua1, myc-Hua1∆N or vector control for their ability to 
interfere with pH-induced processing of HA-Rim101 expressed from a LEU2 plasmid. Co-
transformed cells were grown in minimal media containing 50 µM CuCl2
 to mid-log phase before 
equivalent cell numbers from each sample were harvested and incubated in buffer of indicated pH 
for 20 mins prior to generation of lysates and immunoblot analysis. These experiments were 
performed in both BY4742 (upper) and SEY6210 (lower) parental strains. 
b) Rim101 processing was assessed as described above in SEY6210 cells grown to mid-log 
phase in buffered media (pH = 5.5) containing 50 µM CuCl2
 to induce expression of Rim8-V5, 
Rim8-V5-Ub, and Rim8K>R-V5. Rsp5 levels were also assessed as a control. 
c) Immunoprecipitation experiments in triplicate used for quantitation in Figure 5F. 
d) Immunoprecipitation experiment as described in Figure 5F but using rsp5∆ strains carrying 
TRP1-low copy plasmids expressing wild-type RSP5 or the rsp5∆Ub F618A allele. 
e) Upper, cartoon of the Ste3 pulse chase mating strategy. Mata cells expressing HA tagged STE3 
under control of the GAL1 promoter were grown in minimal media containing 2% galactose. 
Synthesised Ste3 traffics to the plasma membrane where it promotes the cell’s ability to mate with 
Mata cells, before ubiquitin (and Rsp5)-mediated trafficking to the vacuole. When cells are shifted 
to dextrose containing media, the expression of new Ste3 from the GAL1 promoter is shut off and 
the remaining population of Ste3 is free to traffic to the surface and vacuole. Lower, as predicted 
from the assay described above, mating occurs efficiently in cells grown in rich galactose media 
(YPG) and is absent when cells are grown long-term in dextrose media (YPD). Cells were 
transformed with vector control, myc-Hua1, Ub-myc-Hua1 and myc-Hua1∆N and grown to mid-log 
phase in selective minimal media before growth in YPG for 2 hours followed by a 20-minute period 
of growth in YPG to inhibit production of new Ste3. The Hua1 constructs indicated were assessed 
for their ability to compete for the Rsp5-depdendent trafficking of Ste3 from the surface. Mating 
efficiency was assessed by the ability of GAL1-HA-Ste3 expressing cells to mate with Mata cells to 
produce His+ diploids. Inset shows immunoblot of Ste3-HA from cells grown in galactose or 
dextrose.  Right, MATα his3 cells expressing Ste3-HA from the dextrose-repressible GAL1 
promoter and constitutively expressing Ub-Hua1 were grown overnight in galactose media (GAL). 
Dextrose (DEX) was added or not for 10 min prior to mating with MATa his4 cells in rich media 
containing GAL or DEX. Cells were then pelleted, diluted, and spread on -His plates to select for 
diploid cells. The number of diploids from each plate were counted after 2 days growth and plotted. 




















Figure S4. Statistical Analysis 
Related to Figures 6 and 7. 
a) Analysis of variance of differences in the level of plasma membrane localization of Mup1-GFP 
from Figure 6C.  
b)  Immunoblot analysis of WT, ubp2∆, and ubp2 rup1∆ cells expressing myc-Hua1 or the myc-
Hua1K>R mutant from the HUA1 promoter housed on a low copy plasmid. Lysates were blotted with 
α-myc antibodies or α-Rsp5 antibodies and the ratio of Hua1/Rsp5 normalized to WT control are 
plotted (left). Analysis of variance across the genotypes showed no statistical difference (p>0.4) for 
either myc-Hua1 levels or myc-Hua1K>R levels, which were somewhat higher overall. 
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